⏳ Fetching live dividend data...
Home › Calculator › RVXCF Dividend Calculator 2026
Resverlogix Corp. · OTC
Price: $0.08 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in RVXCF → $1411670956533.76M in 10 years · $113,114,659,978,666,690.00/month
Resverlogix Corp., a late-stage clinical biotechnology company, develops therapeutics for disease states with high unmet medical needs. It is developing apabetalone (RVX-208), a small molecule selective bromodomain and extra-terminal inhibitor that is in Phase III clinical trial for patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, end-stage renal disease, and neurodegenerative diseases. Resverlogix Corp. has a partnership with Eversana Life Science Services, LLC to support the pending launch of the commercialization of apabetalone for Covid-19 in the United States and Canada. The company is headquartered in Calgary, Canada.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime.
Ready to invest? Open RVXCF position with:
Real after-tax yield depends on where you live and how you hold RVXCF.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 2500.00% | 2497.20% | $250,000 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 2125.00% | 2122.20% | $212,500 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 2000.00% | 1997.20% | $200,000 / yr |
| 🇬🇧 UK ISA | 0% | 2500.00% | 2497.20% | $250,000 / yr |
| 🇬🇧 UK Taxable | 8.75% | 2281.25% | 2278.45% | $228,125 / yr |
| 🇨🇦 TFSA | 0% | 2500.00% | 2497.20% | $250,000 / yr |
| 🇨🇦 CA Taxable | 25% | 1875.00% | 1872.20% | $187,500 / yr |
| 🇦🇺 Super (pension) | 15% | 2125.00% | 2122.20% | $212,500 / yr |
| 🇦🇺 AU Taxable | 30% | 1750.00% | 1747.20% | $175,000 / yr |
| 🇩🇪 DE Taxable | 26.375% | 1840.63% | 1837.83% | $184,063 / yr |
| 🇫🇷 FR Taxable | 30% | 1750.00% | 1747.20% | $175,000 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
RVXCF pays quarterly — 4 times per year. Next ex-div: TBD.
How RVXCF compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for RVXCF sourced from FMP /financial-growth endpoint — real data, not estimates.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the RVXCF dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →